Vasil'ev S A, Efremov E E, Ermolin G A, Kotelianskiĭ V E, Ignashenkova G V
Ter Arkh. 1986;58(10):117-23.
Plasma fibronectin (FN) is one of the major blood opsonins. The content of the glycoprotein reduces in sepsis which in turn may aggravate the course of the infection. FN is detectable in the content of cryoglobulins and cryofibrinogen. The formation of the heparin precipitate following plasma incubation in the cold in the presence of heparin is determined by FN involvement. Fibrinogen (FG) is another main component of the heparin precipitate. To determine the functional activity of plasma FN in sepsis and other pathological conditions, a study was made of the ability of FN and FG to go into the precipitate formed in blood plasma in the cold after its incubation with heparin. Unlike normal subjects in whom over 80% of FN on the average and about 20% of FG went into the heparin precipitate, in patients with hemoblastoses and aplastic anemia complicated by sepsis, less than 40% of FN on the average and about 7% of FG went into the precipitate. In some patients with sepsis, the heparin precipitate did not form. The reduction of FN ability to go into the heparin precipitate correlated with the gravity of the patients' condition. In uncomplicated hemoblastoses, cryoglobulinemia and cryofibrinogenemia and in immunocomplex pathology, the consumption of FN and FG during heparin precipitate formation did not significantly differ from the control. The data indicate that sepsis patients with blood system pathology may develop not only quantitative FN deficiency in the blood but also disorder of the functional activity of the opsonin.
血浆纤连蛋白(FN)是主要的血液调理素之一。在脓毒症中,这种糖蛋白的含量会降低,进而可能加重感染进程。在冷球蛋白和冷纤维蛋白原中可检测到FN。血浆在冷环境中与肝素孵育后形成肝素沉淀的过程与FN有关。纤维蛋白原(FG)是肝素沉淀的另一个主要成分。为了确定脓毒症及其他病理状况下血浆FN的功能活性,对FN和FG在与肝素孵育后于冷环境中在血浆中形成沉淀的能力进行了研究。与正常受试者相比,正常受试者平均超过80%的FN和约20%的FG会进入肝素沉淀,而患有血液病和再生障碍性贫血并发脓毒症的患者,平均只有不到40%的FN和约7%的FG进入沉淀。在一些脓毒症患者中,未形成肝素沉淀。FN进入肝素沉淀的能力降低与患者病情的严重程度相关。在未并发的血液病、冷球蛋白血症和冷纤维蛋白原血症以及免疫复合物病理状况下,肝素沉淀形成过程中FN和FG的消耗与对照组无显著差异。数据表明,患有血液系统病理状况的脓毒症患者不仅可能出现血液中FN的定量缺乏,还可能出现调理素功能活性紊乱。